BOULDER, COLO. — Breakthrough Properties, a developer of life sciences real estate backed by a joint venture of Tishman Speyer and Bellco Capital, has acquired a 9.3-acre, four-building campus in Boulder. The company plans to transform the campus into a 164,000-square-foot office, lab and flex development named Boulder 38 by Breakthrough.
Located at the intersection of 38th Street and Arapahoe Avenue, the campus is one mile from Jennie Smith Caruthers Biotechnology Building, a 400,000-square-foot research and technology facility at the University of Colorado Boulder.
Research conducted at the university and the surrounding ecosystem has established Boulder as a regional bioscience hub. According to CBRE market report data, the Boulder life sciences market has maintained approximately 1 million square feet of active life science requirements over the past 18 months.
“Boulder has succeeded in cultivating a unique ecosystem propelled by leading research and academic institutions, creative residents and premier outdoor recreational amenities,” says Paul DeMartini, senior managing director of Tishman Speyer. “We are excited by this opportunity to create a world-class research campus that will serve as a magnet for life sciences innovation and talent.”
The acquisition and redevelopment of Boulder 38 is being capitalized by the Breakthrough Life Science Property Fund, which raised $3 billion in direct capital and co-investments. Boulder is the fourth new market Breakthrough has entered since the beginning of the year, including the company’s acquisition of 2300 Market Street in Philadelphia’s Center City district, with plans to redevelop the site for 200,000 square feet of life sciences space.
— Channing Hamilton and Amy Works